Trial Information
Inclusion Criteria:
- Patients with advanced Soft Tissue Sarcoma prior to pazopanib treatment
Exclusion Criteria:
- Other treatment
- FDG negative tumor
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Measure of extent and intensity (standardized uptake value - SUV) of disease demonstrated on PET/CT images before and after treatment.
Outcome Time Frame:
1 week
Authority:
Israel: Ministry of Health
Study ID:
0103-12-HMO
NCT ID:
NCT01594203
Start Date:
May 2012
Completion Date:
May 2013
Related Keywords:
- Soft Tissue Sarcoma (STS)
- Soft Tissue Sarcoma
- Pazopanib
- F18-FDG PET/CT
- Sarcoma